Identifying the Epitope Regions of Therapeutic Antibodies Based on Structure Descriptors.

ABSTRACT: Therapeutic antibodies are widely used for disease detection and specific treatments. However, as an exogenous protein, these antibodies can be detected by the human immune system and elicit a response that can lead to serious illnesses. Therapeutic antibodies can be engineered through antibody humanization, which aims to maintain the specificity and biological function of the original antibodies, and reduce immunogenicity. However, the antibody drug effect is synchronously reduced as more exogenous parts are replaced by human antibodies. Hence, a major challenge in this area is to precisely detect the epitope regions in immunogenic antibodies and guide point mutations of exogenous antibodies to balance both humanization level and drug effect. In this article, the latest dataset of immunog

SUBMITTER:  

PROVIDER: S-EPMC5751102 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature